FIELD: chemistry.
SUBSTANCE: invention refers to the group including hydronopol-substituted benzimidazolone- and quinazolinone-derivatives as agonists of human ORL1 receptors (nociceptors). In addition, the invention refers to making specified compounds, to pharmaceutical compositions containing pharmacologically active amount of at least one specified new benzimidazolone- and quinazolinone-derivatives as an active component, and to application of said pharmaceutical compositions in treatment of disorders involving ORL1 receptors. The invention concerns compounds of general formula where symbols take on values specified in the description.
EFFECT: higher effectiveness of the composition and therapy.
7 cl, 17 ex, tbl
Title | Year | Author | Number |
---|---|---|---|
BENZIMIDAZOLON AND CHINAZOLIN DERIVATIVES AS HUMAN ORL1-RECEPTOR AGONISTS | 2004 |
|
RU2364593C2 |
NEW PHENYLPIPERAZINES | 2000 |
|
RU2246494C2 |
SPIROCYCLIC CYCLOHEXANE DERIVATIVES | 2008 |
|
RU2470933C2 |
HYDRONOPOLE DERIVATIVES AS AGONISTS TO ORL1 HUMAN RECEPTORS | 2004 |
|
RU2351600C2 |
NOVEL DERIVATIVES OF 4,5-DIHYDRO-1H-PYRAZOLE SHOWING CB-ANTAGONISTIC ACTIVITY | 2002 |
|
RU2299199C2 |
DERIVATIVES OF 4,5-DIHYDRO-1H-PYRAZOLE ELICITING CB1-ANTAGONISTIC ACTIVITY | 2001 |
|
RU2245878C2 |
SPIROCYCLIC DERIVATIVES OF CYCLOHEXANE WITH AFFINITY TO ORL1 RECEPTOR | 2004 |
|
RU2383544C2 |
1 H-IMIDAZOLE DERIVATIVES AS MODULATORS OF CANNABINOID CB2 RECEPTORS | 2006 |
|
RU2410377C2 |
DERIVATIVES OF 1H-IMIDAZOLE POSSESSING CB-AGONISTIC, PARTIAL CB-AGONISTIC OR CB-ANTAGONISTIC ACTIVITY | 2002 |
|
RU2299200C2 |
3-TETRAHYDROPYRIDINE-4-YLINDOLES FOR TREATMENT OF PSYCHOTIC DISORDERS | 1999 |
|
RU2222535C2 |
Authors
Dates
2009-06-10—Published
2004-10-01—Filed